Market Research Report
North America Polymerase Chain Reaction Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||837253|
|Published||Content info||82 Pages
Delivery time: 2-3 business days
|North America Polymerase Chain Reaction Market Forecast 2019-2027|
|Published: May 13, 2019||Content info: 82 Pages||
The global polymerase chain reaction market by North America generated a revenue of $XX million in 2018 & is projected to reach $XX million by 2027, at a CAGR of 5.87%. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027.
North America polymerase chain reaction market mainly covers the economic contribution of the countries such as likes of the United States and Canada. North America polymerase chain reaction market is driven mainly by the increasing usage of laboratory techniques coupled with the advent of advanced PCR technologies like q-PCR and RT-PCR which is boosting the market in the North America region during the forecast period of 2019-2027.
Pacific Biosciences of California, Inc., F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Nano BioSys Inc., Biomerieux SA, Bio-Rad Technologies Inc., Becton Dickinson Biosciences Systems and Reagents Inc., Siemens Healthineers, MDXhealth Corporation, Danaher Corporation, Abbott Laboratories, Qiagen N.V., Fluidigm Corporation, Agilent Technologies Inc., and Tahara Bio Inc. are the key companies that are reaping huge revenues for the market, which have been extensively summarized in the report.